Pla Daniel, Marchal Antonio, Olsen Christian A, Francesch Andrés, Cuevas Carmen, Albericio Fernando, Alvarez Mercedes
Institute for Research in Biomedicine, Barcelona Science Park, University of Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain.
J Med Chem. 2006 Jun 1;49(11):3257-68. doi: 10.1021/jm0602458.
The marine alkaloid, Lamellarin D (Lam-D), has shown potent cytotoxicity in numerous cancer cell lines and was recently identified as a potent topoisomerase I inhibitor. A library of open lactone analogues of Lam-D was prepared from a methyl 5,6-dihydropyrrolo[2,1-a]isoquinoline-3-carboxylate scaffold (1) by introducing various aryl groups through sequential and regioselective bromination, followed by Pd(0)-catalyzed Suzuki cross-coupling chemistry. The compounds were obtained in a 24-44% overall yield, and tested in a panel of three human tumor cell lines, MDA-MB-231 (breast), A-549 (lung), and HT-29 (colon), to evaluate their cytotoxic potential. From these data, the SAR study concluded that more than 75% of the open-chain Lam-D analogues tested showed cytotoxicity in a low micromolar GI50 range.
海洋生物碱片螺素D(Lam-D)在众多癌细胞系中显示出强大的细胞毒性,最近被确定为一种有效的拓扑异构酶I抑制剂。通过依次进行区域选择性溴化引入各种芳基,然后进行钯(0)催化的铃木交叉偶联反应,从5,6-二氢吡咯并[2,1-a]异喹啉-3-羧酸甲酯支架(1)制备了片螺素D的开链内酯类似物库。这些化合物的总收率为24-44%,并在一组三种人类肿瘤细胞系MDA-MB-231(乳腺癌)、A-549(肺癌)和HT-29(结肠癌)中进行测试,以评估它们的细胞毒性潜力。根据这些数据,构效关系研究得出结论,超过75%的受试开链片螺素D类似物在低微摩尔浓度的GI50范围内显示出细胞毒性。